Earth Life Sciences Inc. (OTCPK : CLTS) signed an agreement to acquire VIVA Health HK Limited for £18.1 million on October 4, 2021. Under the terms of the agreement, the Company issued 425 million common shares to an escrow agent and upon receiving a satisfactory minimum viable product version and a Beta version completed and demonstrated with necessary support documentation, the Escrow Agent will transfer the shares to Viva. A further issuance of 750 million shares will be issued upon the O2O website going fully live and operational.

All shares being issued are restricted. The company plans to change its name to VIVA USA.